Injections of botulinum toxin preparations firmly hold the leading position among the cosmetic procedures that patients seek. Both women and men strive to smooth out wrinkles, especially those formed in the area around the eyes. However, some side effects – such as post-injection swelling can reduce patient satisfaction and require additional rehabilitation procedures.
estet-portal.com reminds that careful questioning of the patient before the administration of the drug, or taking preventive measures will help to avoid edema. And if, nevertheless, there is a history of a tendency to edema after botulinum therapy, then the injectable medical preparation MESOEYE&trade will help prevent or reduce the severity and duration of edema; C71 from Emet™.
Causes of edema after botulinum toxin administration
Not any swelling after botulinum therapy is considered a complication. Sometimes it may just be the body's reaction to the needle prick. Such edema appears immediately after the procedure and soon subsides, and for 2-3 days there is no trace of it.
Much more serious troubles are edema, which appear about a week after botulinum therapy, when the drug begins to immobilize the mimic muscles of the face. They can last for several weeks and even months, for their correction it is necessary to carry out special corrective procedures in order to restore a healthy look to the face.
In order to minimize the risk of edema formation after botulinum toxin therapy, a thorough history taking of the patient is necessary.
Risk factors for kidney disease, liver disease, cardiovascular problems, recent surgery, including plastic surgery. The presence of fatty hernial sacs of the upper and lower eyelids can push the trouble.
It is imperative to ask the patient if he is prone to edema at all. Even if the patient does not have a history of diseases that have clinical manifestations of edema, at a certain age, dystrophy of collagen fibers, a violation of the qualitative composition of the intercellular matrix and fibroblast function is always present, because tissue aging – it is an inevitable process.
The same problems are present in the microcirculation system of facial tissues, and especially in the periorbital zone. Even a slight violation of vascular function can provoke swelling of this area after botulinum therapy.
After all, the relaxation of the muscle, which compensated for the decrease in the tone of the vascular wall itself, after botulinum therapy, will entail a violation of this "homeostasis", the walls of the vessels will need time to adapt to new conditions. Clinically, this can be manifested by swelling of nearby tissues for some time, which causes some discomfort to patients and may even require additional methods of treatment.
With age, the skin acquires signs of age-related changes, and prolonged swelling can lead to the violation of trophism and the acceleration of the aging process of the skin with the formation of a network of superficial wrinkles in the area around the eyes.
The following can make the problem worse:
• heart failure – it is characterized by a weakening of the outflow of venous blood, and inactivity of the muscles of the face after injection provokes swelling of the eyelids or the entire face;
• diseases of the urinary system – the reduced ability of the kidneys to excrete mineral salts leads to their settling in the tissues and the formation of edema, most often on the face, and the exclusion of muscle contractions exacerbates their manifestation;
• hormonal imbalance – female sex hormones greatly affect the ability of tissues to retain fluid, and many observe slight swelling of the face during pregnancy and on certain days of the menstrual cycle;
Emet™.
How to correct and prevent edema after botulinum toxin therapyIn order to prevent the risk of edema development after the injection of botulinum toxins in the periorbital area, a good solution would be to prepare the patient for the procedure by stimulating microcirculation and strengthening the vascular walls. The drug of choice for this preparation is MESOEYE™ C71.
The innovativeness of the drug is that its active components are able to effectively and safely restore the activity of all three vascular systems of the microcirculation zone around the eyes – arterial, venous and lymphatic.
This injectable preparation effectively prevents edema in the periorbital region due to the selective therapeutic effect on microcirculation:
• relieves spasms of blood vessels of the arterial system;
• slows down the processes of pathological protein glycation;
• eliminates vasodilation of the venous system and reduces their permeability;
• activates lymph flow.
• Hexapeptide 17– From 71 – directly activates the lymph flow, increases the number of actively functioning vessels of the arterial system, as well as the speed and volume of blood flow in them, which improves microcirculation in the dermis and subcutaneous fatty tissue,
• eliminates the pathological expansion of the vessels of the venous system and reduces their permeability;
• PeriOrbitalPeptide XP2 – relieves spasms of blood vessels of the arterial system due to inhibition of angiotensin-converting enzyme, restores and protects collagen fibers by slowing down pathological glycation;
• DRMC complex – moisturizes and nourishes the skin due to the content of hyaluronic acid, a complex of amino acids, vitamins, nucleosides.
MESOEYE™ C71 from Emet™ becomes part of a comprehensive correction program aimed at eliminating stagnation of lymph and blood. Its introduction can be combined with manual massage and hardware effects.
Add a comment